Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO).
Zamboglou C, Aebersold DM, Albrecht C, Boehmer D, Ganswindt U, Schmidt-Hegemann NS, Hoecht S, Hölscher T, Koerber SA, Mueller AC, Niehoff P, Peeken JC, Pinkawa M, Polat B, Spohn SKB, Wolf F, Zips D, Wiegel T. Zamboglou C, et al. Among authors: polat b. Strahlenther Onkol. 2025 Jan;201(1):4-10. doi: 10.1007/s00066-024-02288-6. Epub 2024 Aug 28. Strahlenther Onkol. 2025. PMID: 39196366
Prostate cancer and elective nodal radiation therapy for cN0 and pN0-a never ending story? : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO).
Koerber SA, Höcht S, Aebersold D, Albrecht C, Boehmer D, Ganswindt U, Schmidt-Hegemann NS, Hölscher T, Mueller AC, Niehoff P, Peeken JC, Pinkawa M, Polat B, Spohn SKB, Wolf F, Zamboglou C, Zips D, Wiegel T. Koerber SA, et al. Among authors: polat b. Strahlenther Onkol. 2024 Mar;200(3):181-187. doi: 10.1007/s00066-023-02193-4. Epub 2024 Jan 25. Strahlenther Onkol. 2024. PMID: 38273135 Free PMC article. Review.
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial.
Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Schär C, Sumila M, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti DG, Khanfir K, Gomez S, Wust P, Thalmann GN, Aebersold DM; Swiss Group for Clinical Cancer Research (SAKK). Ghadjar P, et al. Among authors: polat b. Eur Urol. 2021 Sep;80(3):306-315. doi: 10.1016/j.eururo.2021.05.033. Epub 2021 Jun 14. Eur Urol. 2021. PMID: 34140144 Clinical Trial.
Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial.
Beck M, Sassowsky M, Schär S, Mathier E, Halter M, Zwahlen DR, Hölscher T, Arnold W, Polat B, Hildebrandt G, Müller AC, Putora PM, Papachristofilou A, Hayoz S, Schär C, Li Q, Sumila M, Zaugg K, Guckenberger M, Ost P, Bosetti DG, Reuter C, Gomez S, Khanfir K, Aebersold DM, Ghadjar P, Pra AD. Beck M, et al. Among authors: polat b. Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):80-91. doi: 10.1016/j.ijrobp.2021.12.174. Epub 2022 Jan 3. Int J Radiat Oncol Biol Phys. 2022. PMID: 34990777 Free article.
Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10.
Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Stein J, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller AC, Putora PM, Papachristofilou A, Schär C, Dal Pra A, Biaggi Rudolf C, Wust P, Aebersold DM, Thalmann GN; Swiss Group for Clinical Cancer Research (SAKK). Ghadjar P, et al. Among authors: polat b. Radiother Oncol. 2018 Feb;126(2):257-262. doi: 10.1016/j.radonc.2017.10.025. Epub 2017 Nov 3. Radiother Oncol. 2018. PMID: 29103826 Clinical Trial.
Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer.
Tamihardja J, Lawrenz I, Lutyj P, Weick S, Guckenberger M, Polat B, Flentje M. Tamihardja J, et al. Among authors: polat b. Strahlenther Onkol. 2022 Aug;198(8):735-743. doi: 10.1007/s00066-022-01953-y. Epub 2022 May 12. Strahlenther Onkol. 2022. PMID: 35551434 Free PMC article.
Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer-a two center experience.
Mantel F, Müller E, Kleine P, Zimmermann M, Exner F, Richter A, Weick S, Ströhle S, Polat B, Höcht S, Flentje M. Mantel F, et al. Among authors: polat b. Strahlenther Onkol. 2021 May;197(5):405-415. doi: 10.1007/s00066-021-01756-7. Epub 2021 Mar 16. Strahlenther Onkol. 2021. PMID: 33725133 Free PMC article.
371 results